Demographics of the symptomatic RSV LRTI group and controls
| Symptomatic RSV LRTI group | Controls | p value | |
|---|---|---|---|
| (n = 15) | (n = 24) | ||
| Data are shown as median (range) or n (%). | |||
| Gestational age (wk) | 28 (24–31) | 28 (24–31) | 0.30 |
| Birth weight (kg) | 1.08 (0.38) | 1.09 (0.38) | 0.94 |
| Males | 10 (66%) | 13 (54%) | 0.26 |
| Antenatal smoking | 2 (13%) | 3 (12%) | 0.98 |
| Antenatal steroids | 12 (80%) | 18 (69%) | 0.62 |
| Surfactant | 10 (66%) | 17 (71%) | 0.63 |
| Duration of ventilation (days) | 6 (0–30) | 6 (0–79) | 0.96 |
| Bronchopulmonary dysplasia | 10 (67%) | 14 (58%) | 0.82 |
| Parental atopy | 5 (33%) | 10 (41%) | 0.96 |
| Postnatal smoking | 2 (13%) | 4 (16%) | 0.89 |
| Day care | 5 (33%) | 4 (16%) | 0.34 |
| Number of siblings | 1 (0–3) | 1 (0–4) | 0.67 |
| Palivizumab | 2 (13%) | 4 (17%) | 0.92 |